Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.8708
+0.0333 (3.98%)
At close: Sep 16, 2025, 4:00 PM EDT
0.9000
+0.0292 (3.35%)
After-hours: Sep 16, 2025, 4:31 PM EDT
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $9.29 million as of September 16, 2025. Its market cap has increased by 64.30% in one year.
Market Cap
9.29M
Enterprise Value
6.69M
1-Year Change
64.30%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $9.29M, a decrease of -73.67%. That is a compound annual growth rate of -29.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 8.93M | 5.78% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
| Oct 29, 2021 | 35.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |